Skip Navigation

About Myelodysplastic/Myeloproliferative Diseases

  • Myelodysplastic/myeloproliferative diseases: a group of diseases in which the bone marrow does not make enough healthy blood cells

    Myelodysplastic/myeloproliferative diseases (neoplasms) are a group of diseases in which the bone marrow makes too many white blood cells. Myelodysplastic/myeloproliferative neoplasms have features of both myelodysplastic syndromes (MDS) and myeloproliferative neoplasms.

    In myelodysplastic diseases, the blood stem cells do not mature into healthy red blood cells, white blood cells, or platelets. The immature blood cells do not work as they should and die in the bone marrow or soon after they enter the blood. As a result, there are fewer healthy red blood cells, white blood cells, and platelets.

    In myeloproliferative diseases, a greater than normal number of blood stem cells become one or more types of blood cells, and the total number of blood cells slowly increases.

    Learn about myelodysplastic/myeloproliferative diseases, and find information on how we support and care for people with these diseases before, during, and after treatment.

    The following information is from the National Cancer Institute (NCI).


  • Services and Support at Dana-Farber

    patient and technician

    Becoming a Patient

    As a new Dana-Farber patient, find answers to questions about your first visit: what to bring, how to find us, where to park, and how to prepare.

    patient ratings pie chart

    How Our Blood Cancer Patients Rate Dana-Farber

    Take a look at our patient satisfaction survey results for our patients treated for various blood cancers.
    cover supportive resources brochure

    Support Services and Amenities

    We offer a wide range of services, from financial planning to creative arts to spiritual counsel, to support our patients through their cancer experiences.